Robot Surgery Boosts Head and Neck Cancer Survival Rates by 30%

Robot-assisted surgery is revolutionizing the treatment of head and neck cancers, leading to a remarkable increase in survival rates, particularly for oropharyngeal and laryngeal cancers. Previously, treating these cancers often required extensive procedures like jaw removal or partial/total laryngectomy, frequently resulting in significant functional impairments in breathing, swallowing, and speech.

However, robotic surgery enables surgeons to operate with greater precision through minimally invasive techniques. Utilizing thin robotic arms and high-definition 3D imaging, surgeons can target tumors more accurately, preserving surrounding healthy tissues. This approach is especially beneficial for cancers located in difficult-to-reach areas within the pharynx and larynx, accessed through the oral cavity without the need for external incisions.

This advancement has led to substantial improvements in patient outcomes. For advanced oropharyngeal cancer patients, survival rates have reportedly climbed by about 30 percentage points, reaching approximately 78% for the 5-year survival rate. Similarly, for laryngeal cancer, the survival rate has improved to around 69%. These figures represent a significant leap forward and are considered among the best globally.

The protocol often involves a combination of treatments, starting with neoadjuvant chemotherapy to shrink tumors, followed by robotic surgery to remove the cancerous tissue while maximizing functional preservation. Post-operative radiation and chemotherapy may be administered based on pathological findings to minimize the risk of recurrence. The success of these robotic procedures, particularly for oropharyngeal cancers, has been recognized and published in prestigious medical journals.

“

The survival rate for patients with advanced oropharyngeal and laryngeal cancer, which was previously as low as 50% and 30% respectively, has now increased by about 30 percentage points to 78% and 69%.